Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

A blood filter shows promise in treating sepsis

November 6, 2018 By Danielle Kirsh

Sinead Miller

Sinead Miller, CEO and cofounder of PathEx [Image from Sinead Miller]

After early work with magnetic nanoparticles, Path Ex co-founder & CEO Sinead Miller turned to a common blood collection technique for inspiration.

By John Minichillo

An elite cyclist turned medtech researcher, Sinead Miller may be in her greatest race yet — developing technology to treat sepsis, a major killer in U.S. healthcare settings.

An overwhelming immune response to infection, sepsis affects about 1 million Americans a year, killing up to nearly a third of them, according to NIH. To combat it, Miller initially focused on developing nanoparticles to magnetically extract bacteria from the blood while working as a graduate research assistant in recent years at Vanderbilt University.

But although the lab successfully bound bacteria to the nanoparticles and removed them from small blood samples, the process wasn’t scalable to human blood volumes, Miller told Medical Design & Outsourcing. Miller needed to find another solution.

“I developed a mathematical model to simulate the design, and through computational modeling, I found it wasn’t going to work. This eventually led to the idea of using inertial force to separate bacteria from healthy blood components,” said Miller, now the co-founder and CEO of a startup called Path Ex.

Inertial force is already used to separate blood components in apheresis machines. This concept, combined with her experience with nanoparticles, led to the idea behind the Path Ex blood filtration technology, she explained.

Bad crash with a good outcome

Miller knows what it’s like to overcome a major challenge. Miller, who grew up competing in bike races, went to Marian University in Indianapolis on a cycling scholarship and joined the U.S. National Team with a goal to compete in the Olympics. Her dream came to an end in 2010, when a severe crash in the Netherlands caused severe brain injury and numerous broken bones. She was out of school for a year while she recovered.

“[The experience] inspired me to want get into medicine, but I knew I didn’t want to be a physician. I wanted to be the person developing the technology, so I went into biomedical engineering,” she told MDO.

As a woman in a male-dominated field, Miller said she’s never felt that gender prejudice held her back.

“There are fewer women in the field, but I can’t say I’ve had any negative experiences because of that.” she said. “When we go to pitch, the investors are mostly male, but that has never been an issue for us.  It’s been fair.”

Bacteria are bad but so are the endotoxins

Technically not a filter, the Path Ex device works through adhesion. Using a dialysis-like device, it pumps blood through a helical channel that creates inertial forces to separate bacteria from healthy blood components, based on their size and shape. A coating in the channel binds to bacteria that are specific to pathogens and endotoxins. Referred to as a filter because it removes bacteria from the blood, treatment with the device takes about the same time as a hemodialysis session, anywhere from four to 24 hours.

Miller said that the applications for the Path Ex device could extend beyond sepsis, noting that a few small tweaks would allow it to target blood-borne diseases. And, she noted, it can do something that antibiotics can’t do: physically eliminate bacteria cells.

John Kellum, professor of critical care medicine at the University of Pittsburgh and director of the Center for Critical Care and Nephrology, said bacterial die-off often leads to a common side effect of antibiotic treatment.

“An example of that happens very commonly when patients are admitted who are ‘teetering on the brink.’ They’re given antibiotics and before they get better, they get worse,” Kellum explained. “Most of the antibiotics that we use, by virtue of killing the bacteria, actually release bacterial products into the bloodstream. Therefore, there could be a role in the use of something to clean up the blood of bacterial products even in the setting of effective antibiotic therapy.”

In the end, however, removing endotoxins could prove the more significant benefit of the Path Ex device. That’s because these by-products cause a massive reaction in about a third of sepsis patients, Kellum said.

“The reason endotoxin hurts you is not because it’s intrinsically toxic, but because it binds with a receptor and then causes a massive endogenous inflammatory reaction. About one-third of the patients with septic shock have detectable levels of endotoxin in the bloodstream, at least at some point. And the more they have the worse they do,” Kellum explained.

Check out a list of 100 top women leaders in the medical device industry >>

Related Articles Read More >

Sandia mask
Sandia Labs seeks partners to make reusable masks
MSA Safety Advantage 290 elastomeric respirator
3M, others may have unmasked a solution to future N95 shortages
Qosina adds 12 new fluid and gas filters
Schurter debuts smaller filters for cramped quarters

DeviceTalks Weekly.

May 20, 2022
DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech